Avadel Pharmaceuticals plc (AVDL)
NASDAQ: AVDL · Real-Time Price · USD
9.20
-0.09 (-0.97%)
Jun 27, 2025, 4:00 PM - Market closed

Avadel Pharmaceuticals Market Cap

Avadel Pharmaceuticals has a market cap or net worth of $890.00 million as of June 27, 2025. Its market cap has decreased by -39.36% in one year.

Market Cap
890.00M
Enterprise Value
863.90M
1-Year Change
-39.36%
Ranking
Category
Stock Price
$9.20

Market Cap Chart

Since December 31, 2002, Avadel Pharmaceuticals's market cap has increased from $70.50M to $890.00M, an increase of 1,162.41%. That is a compound annual growth rate of 11.93%.

History

DateMarket Cap% Change
Jun 27, 2025890.00M-12.12%
Dec 31, 20241.01B-20.13%
Dec 29, 20231.27B186.71%
Dec 30, 2022442.30M-6.63%
Dec 31, 2021473.70M21.68%
Dec 31, 2020389.30M37.71%
Dec 31, 2019282.70M196.02%
Dec 31, 201895.50M-70.71%
Dec 29, 2017326.10M-23.90%
Dec 30, 2016428.50M-12.68%
Dec 31, 2015490.70M11.85%
Dec 31, 2014438.70M118.37%
Dec 31, 2013200.90M165.74%
Dec 31, 201275.60M-41.12%
Dec 30, 2011128.40M-22.88%
Dec 31, 2010166.50M-7.04%
Dec 31, 2009179.10M89.93%
Dec 31, 200894.30M-60.61%
Dec 31, 2007239.40M-66.28%
Dec 29, 2006710.00M72.88%
Dec 30, 2005410.70M-1.49%
Dec 31, 2004416.90M-3.92%
Dec 31, 2003433.90M515.46%
Dec 31, 200270.50M-
View and export this data all the way back to 2002. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 696.15B
Johnson & Johnson 366.71B
AbbVie 322.03B
Novo Nordisk 304.96B
UnitedHealth Group 280.41B
Novartis AG 235.85B
Abbott Laboratories 233.80B
AstraZeneca 217.42B
Market Cap Rankings